Baxter International Inc. (LON:0QK8)
London
· Delayed Price · Currency is GBP · Price in USD | Market Cap | 11.65B |
| Revenue (ttm) | 8.50B |
| Net Income (ttm) | -518.40M |
| Shares Out | n/a |
| EPS (ttm) | -1.02 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 0.72 (2.38%) |
| Ex-Dividend Date | Feb 28, 2025 |
| Volume | 1,654 |
| Average Volume | 1,744 |
| Open | 30.22 |
| Previous Close | 30.15 |
| Day's Range | 30.11 - 30.46 |
| 52-Week Range | 27.81 - 50.11 |
| Beta | n/a |
| RSI | 47.00 |
| Earnings Date | May 8, 2025 |
About Baxter International
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; administrative sets; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technolog... [Read more]
News
Baxter: Messy, Yet Appealing, If New Management Can Deliver
Baxter’s valuation looks fair, but high debt, pressured earnings, and a reduced dividend make the outlook murky. Check out why BAX stock is a hold.
What Does the Market Think About Baxter Intl?
Baxter Intl's (NYSE: BAX) short percent of float has risen 13.65% since its last report. The company recently reported that it has 18.16 million shares sold short , which is 5.33% of all regular shar...
Goldman's John Marshall provides stock opportunities ahead of earning season
John Marshall, Goldman Sachs head of derivatives research, joins 'Money Movers' to discuss the current market environment, individual companies Goldman looked at, and much more.
Baxter Launches New Room Temperature Hemopatch Sealing Hemostat for Rapid and Convenient Application During Surgery
VIENNA--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the introduction of Hemopatch Sealing Hemostat with room temperature st...
Peering Into Baxter Intl's Recent Short Interest
Baxter Intl's (NYSE: BAX) short percent of float has fallen 12.66% since its last report. The company recently reported that it has 18.33 million shares sold short , which is 4.69% of all regular sha...
Baxter to Host Annual Meeting of Stockholders in Virtual Format
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host its Annual Meeting of Stockholders (the 2025 Annual Meeting) in a virtual format on Tuesday, ...
Baxter International (BAX) Engages Stockholders with New Presentation
Baxter International (BAX) Engages Stockholders with New Presentation
Stocks beating the stock market's recent Trump slump have this in common
This year's top performer among the S&P 500 has been CVS Health's stock, which had a bad 2024 and is cheap by a key valuation measure.
DraftKings To Rally Over 29%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page . Barclays ...
Baxter Unveils Voalte Linq Device Powered by Scotty Assistant at HIMSS25 to Advance Voice-Activated Technology in Hospital Settings
LAS VEGAS--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today unveiled Voalte Linq device powered by Scotty assistant, the company's first voice-activated technology...
Labor backs local IV fluid maker to hedge against supply shocks
Labor will invest $20 million in Baxter Healthcare’s IV fluid production facility in western Sydney.
Medical Penlight Market Report 2025-2030, with BV Medical, Aspen Surgical Products, Baxter, Streamlight, GF Health Products, Rudolf Riester, American Diagnostic, HONSUN, Prestige Medical & more
Dublin, March 03, 2025 (GLOBE NEWSWIRE) -- The "Medical Penlight Market Size, Share & Trends Analysis Report By Type (Consumables, Equipment), By Light Output (Oncology, Cardiovascular Diseases), By U...
Baxter International files for automatic mixed securities shelf
Baxter to Present at Barclays 27th Annual Global Healthcare Conference
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Barclays 27th Annual Global Healthcare Conference on Wednesday, March 12, 2025. Joe...
Why Baxter International Inc (BAX) May Struggle to Outperform: A Look at Future Challenges
Why Baxter International Inc (BAX) May Struggle to Outperform: A Look at Future Challenges
Decoding Baxter International Inc (BAX): A Strategic SWOT Insight
Decoding Baxter International Inc (BAX): A Strategic SWOT Insight
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2192425155-1eb66f6fd4184db08574a9f44228cbaa.jpg)
Medical Device Maker Baxter International's Stock Soars on Strong Earnings
Baxter International shares surged Thursday after the medical device maker's fourth-quarter results topped estimates.
Baxter International Inc. 2024 Q4 - Results - Earnings Call Presentation
Baxter targets 5%-6% 2025 revenue growth amid Novum IQ pump success and operational recovery
Baxter International Inc. (BAX) Q4 2024 Earnings Conference Call Transcript
Baxter Q4 Earnings Beat Expectations, Issues Strong 2025 Outlook
On Thursday, Baxter International Inc. (NYSE: BAX) reported a fourth-quarter 2024 adjusted EPS of 58 cents, beating the management guidance of 50 cents-53 cents and the Wall Street estimate of 52 cen...
Baxter Q4 Earnings Beat Expectations, Issues Strong 2025 Outlook
On Thursday, Baxter International Inc. BAX reported a fourth-quarter 2024 adjusted EPS of 58 cents, beating the management guidance of 50 cents-53 cents and the Wall Street estimate of 52 cents.
Earnings Summary: Highlights of Baxter International’s Q4 2024 report
Baxter International Inc. (NYSE: BAX) on Thursday announced financial results for the fourth quarter of 2024. The medical device maker’s sales increased modestly during the quarter. Fourth-quarter sal...
Baxter rises as Q4 results exceed guidance
Baxter forecasts 2025 profit above estimates on medical device demand; shares rise
Baxter International on Thursday forecast 2025 profit above Wall Street estimates banking on strong sales of its medical devices, sending the company's shares up 7% in premarket trade.